Possible predictors of response to clonazepam augmentation therapy in patients with protracted depression

Human Psychopharmacology

Volumn 22, Issue 1, 2007, Pages 27-31

  Morishita, Shigeru ^a   Arita, Seizaburo ^b  

^a Kyoto Jujo Rehabilitation Hospital   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Antidepressant; Clonazepam; Depression; Dosage; Family history; Predictor

Indexed keywords

CLONAZEPAM;

ADULT; AGE; AGED; ARTICLE; COHORT ANALYSIS; DATA ANALYSIS; DEPRESSION; DISEASE CLASSIFICATION; DRUG RESPONSE; FAMILY HISTORY; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; CHRONIC DISEASE; CLONAZEPAM; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; GABA MODULATORS; HUMANS; JAPAN; MALE; MIDDLE AGED; PERSONALITY INVENTORY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 33846632385     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.818     Document Type: Article

References (33)

1. Browne TR. 1978. Clonazepam. N Engl J Med 299: 812-816.
2. Chawick D, Hallet M, Harris R. 1977. Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor and clonazepam. Brain 100: 455-466.
3. Goodwin FK, Murphy DL, Bunney WE, Jr. 1972. Lithium response in unipolar versus bipolar depression. Am J Psychiatry 129: 44-47.
4. Jones BD, Chouinard G. 1985. Clonazepam in the treatment of recurrent symptoms of depression and anxiety in a patient with systemic lupus erythematosus. Am J Psychiatry 142: 354-355.
5. Kessler RC, McGonagle KA, Zhao S, et al. 1994. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 51: 8-19.
6. Kishimoto A, Kamata K, Sugihara T. 1988. Treatment of depression with clonazepam. Acta Psychiatr Scand 77: 81-86.
7. Klein DN, Schatsberg AF, McCullough JP. 1999a. Early-versus lateonset dysthymic disorder: comparison in outpatients with superimposed major depressive episodes. J Affect Disord 52: 187-196.
8. Klein DN, Schatzberg AF, McCullough JP. 1999b. Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. J Affect Disord 55: 149-157.
9. Londborg PD, Smith WT, Glaudi V, Painter JR. 2000. Short-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression. J Affect Disord 61: 73-79.
10. Mas F, Prichep LS, Alper K. 1993. Treatment resistant depression in a case of minor head injury: an electrophysiological hypothesis. Clin Electroencephalogr 24: 118-122.
11. Modai I, Zemishlany Z, Jerushalmy Z. 1984. 5-Hydroxytriptamine uptake by blood platelets of unipolar and bipolar depressed patients. Neuropsychobiology 12: 93-95.
12. Morishita S, Aoki S. 1999. Clonazepam in the treatment of prolonged depression. J Affect Disord 53: 275-278.
13. Morishita S, Aoki S. 2002. Clonazepam augmentation of antidepressants: does it distinguish unipolar from bipolar depression? J Affect Disord 71: 217-220.
14. Morishita S, Arita S. 2003a. The period of onset of action of clonazepam augmentation as a mood stabilizer for protracted depression. Int Med J 10: 3-6.
15. Morishita S, Arita S. 2003b. Possible predictors of response to fluvoxamine for depression. Hum Psychopharmacol Clin Exp 18: 197-200; DOI: 10.1002/hup.469.
16. Morishita S, Arita S. 2004. Differential effects of fluvoxamine, paroxetine and milnacipran for depression, especially with regard to age. Hum Psychopharmacol Clin Exp 19: 405-408; DOI:10.1002/hup.608.
17. Morishita S, Aoki S, Watanabe S. 1998. Clonazepam as a thepapeutic adjunct to improve the management of psychiatric disorders. Neuropsychiatry Clin Neurosci 52: 75-78.
18. Nardi A, Perna G. 2006. Clonazepam in the treatment of psychiatric disorders: an update. Int Clin Psychopharmacol 21: 131-142.
19. Nelson MR, Dunner DL. 1995. Clinical and differential diagnostic aspects of treatment-resistant depression. J Psychiatr Res 29: 43-50.
20. Oglivie AD, Battersby S, Budd VJ. 1996. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet 347: 731-733.
21. Pratt JA, Jenner P, Marsden CD. 1985. Clonazepam of the effects of benzodiazepines and other anticonvulsant drugs on synthesis and utilization of 5-HT in mouse brain. Neuropharmacology 24: 59-68.
22. Ros S, Aguera L, de la Gandara J, Rojo JE, de Pedro JM. 2005. Potentiation strategies for treatment-resistant depression. Acta Psychiatr Scand 112: (Suppl 428): 14-24.
23. Rush AJ, Thase ME, Dube S. 2003. Research issues in the study of difficult-to-treat depression. Biol Psychiatry 53: 743-753.
24. Scott J. 1988. Chronic depression. Br J Psychiatry 153: 287-297.
25. Sharma V. 2006. Treatment resistance in unipolar depression: is it an iatrogenic phenomenon caused by antidepressant treatment of patients with a bipolar diathesis? Med Hypotheses 67: 1142-1145; DOI: 10.1016/ j.mehy.2006.04.058.
26. Silverstone T. 1988. Response to bromocriptine distinguishes bipolar from unipolar depression. Lancet 1: 903-904.
27. Smith WT, Londborg PD, Glaudin V, Painter JR. 1998. Short-term augmentation of fluoxetine with clonazepam in the treatment of depression: a double-blind study. Am J Psychiatry 155: 1339-1345.
28. Smith WT, Londborg PD, Glaudin V, Painter JR. 2002. Is extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression? J Affect Disord 70: 251-259.
29. Sugimoto T, Murata T, Omori M, Wada Y. 2003. Clonazepam augmentation therapy in a male at early adolescence with rapid cycling bipolar disorder. Gen Hosp Psychiatry 25: 57-59.
30. Svestka J, Ceskova E, Kamenicka V, Buresova A. 1995. Effectiveness of clonazepam in depressive disorders. Ceska a Slovenska Psychiatrie 91: 199-207 (in Czech).
31. Watanabe S, Yokoyama S (ed.). 1983, Drug Treatment of Depression. Shinkoh Igaku Shuppan: Tokyo; 133-143.
32. Winkler D, Willet M, Wolf R. 2003. Clonazepam in the long-term treatment of patients with unipolar depression, bipolar and schizoaffective disorder. Eur Neuropsychopharmacol 13: 129-134; DOI: 10.1016/ S0924-977X(02)00174-8.
33. Zetin M, Freedman MJ. 1986. Clonazepam in bipolar affective disorder. Am J Psychiatry 143: 1058.